Is MRK or MSLE more undervalued in 2026?

CirclFi compares Merck & Company, Inc. (MRK) and Satellos Bioscience Inc. (MSLE) using 13 institutional-grade valuation models. MRK has a Quality of Company score of 9.8/10 while MSLE scores 3.7/10.

Which is a better buy — MRK or MSLE?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do MRK and MSLE valuations compare?

MRK at $118.72 and MSLE at $7.30 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

MRK vs MSLE Valuation Comparison 2026 — Intrinsic Value Analysis

MRK

Pharmaceutical Preparations

Merck & Company, Inc.

Quality

9.8

out of 10

Value Trap

—

Price

$118.72

Last close

Models

13/13

Active

MSLE

Pharmaceutical Preparations

Satellos Bioscience Inc.

Quality

3.7

out of 10

Value Trap

—

Price

$7.30

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	MRK Fair Value	MRK Upside	MSLE Fair Value	MSLE Upside
Bayesian DCF	Intrinsic	$67.39	-43.2%	$3.04	-58.4%
Earnings Power Value	Intrinsic	$17.85	-85.0%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$10.61	-91.1%	$2.48	-66.1%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for MRK vs MSLE — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

MRK vs MSLE — Which Stock Is More Undervalued?

MRK scores higher with a 9.8/10 quality rating vs MSLE's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Merck & Company, Inc. (MRK) and Satellos Bioscience Inc. (MSLE) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

MRK currently trades at $118.72 with a QOC of 9.8/10, while MSLE trades at $7.30 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).